CVS stops sale of heartburn drugs with suspect contaminant

Packages and pills of Zantac, a popular medication which decreases stomach acid production and prevents heartburn, sit on a table on Sept. 19, 2019, in New York City. The FDA recently announced that is has found small amounts of a probable carcinogen in versions of Zantac and other forms of ranitidine.
Drew Angerer | Getty Images file
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.